• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login/ Register
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Month: February 2023

Finance

Biose Industrie to receive €80M in investment to boost workforce and manufacturing capabilities

February 17, 2023 Microbiome Times

L-GAM and the French State through the “French Tech Souveraineté” scheme have signed a purchase agreement with the aim of acquiring joint control of Biose Industrie, a world leader in the development and production of […]

Pharma & Human Health

Regulatory pathway needs to be developed to make the most of phages

February 16, 2023 Microbiome Times

A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned. France, Belgium and Poland are already developing programmes that take advantage […]

Finance

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

February 10, 2023 Microbiome Times

Prokarium, a biopharmaceutical company leading the oncology field of microbial immunotherapy, has raised $30 million in new funding. This follows Prokarium’s announcement of partnering with Ginkgo Bioworks to leverage its world-class Foundry and extensive Codebase […]

Finance

ADM Opens More Than $30 Million State-of-the-Art Production Facility in Spain

February 8, 2023 Microbiome Times

ADM (NYSE: ADM), one of the world’s leaders in science-backed nutrition solutions, announced that it has opened a new production facility in Valencia, Spain to help meet rising global demand for probiotics, postbiotics and other […]

Pharma & Human Health

Call for Experts – A Survey on Microbiome-Based Biomarker Development

February 7, 2023 Microbiome Times

The EU-funded coordination and support project “Human Microbiome Action” is seeking experts in microbiome-based biomarker development to partake in a Delphi survey. A Delphi Survey is a recognised research practice whereby experts reach a consensus […]

Pharma & Human Health

MD Anderson and Federation Bio to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

February 2, 2023 Microbiome Times

The University of Texas MD Anderson Cancer Center and Federation Bio, a biotechnology company pioneering bacterial cell therapies, today announced a strategic collaboration to design and manufacture a complex, synthetic microbial consortium with the goal […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • “Probiotics” Green-lit for market-usage by French Authorities
    January 25, 2023
  • Microbiome Drug Development: 2022 in Review
    December 30, 2022
  • Exclusive Interview with Ken Blount, VP Microbiome Research at Ferring Pharmaceuticals
    December 22, 2022
  • FDA Approves First Fecal Microbiota Product
    December 1, 2022
  • Proge Farm claims Europe’s first regulatory approval for a microbiome-based therapeutic
    November 29, 2022
sign up

Sign up to the Microbiome Times newsletter